FDA’s Popular CMMI Maturity Model Appraisal Program Soldiers On In Spite Of COVID-19
Virtual CMMI appraisals could be on the way
The Case for Quality Voluntary Improvement Program, run jointly by the US FDA and the Medical Device Innovation Consortium, is leaning heavily on remote quarterly checkpoint meetings with participants in lieu of on-site appraisals. CFQ VIP aims to elevate product, manufacturing and process quality at device firms by assessing the companies against a modified version of the Capability Maturity Model Integration (CMMI) framework.
